
Development of innovative treatments for chronic serious diseases with metabolic pathophysiology, focusing on non-alcoholic steatohepatitis (NASH) and rare disorders.
A
CSR Analysis score
The organization is among the top 5% of organizations with the most committed CSR positioning, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
Leading organizations
Orphan Europe
B
Development and commercialization of drugs for rare diseases.
mrgm_france
B
Research on molecular mechanisms of rare diseases, identifying and characterizing candidate genes linked to various rare diseases, investigating mitochondrial bioenergetics and dynamics.
Takeda
B
Development and commercialization of innovative medicines in various therapeutic areas, including gastrointestinal diseases, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines.
Initiatives identified among leaders
Développement de programmes de responsabilité sociale
“Takeda développe des programmes de responsabilité ...” - Takedaprise d'engagement pour la protection de l'environnement et la responsabilité sociétale
“Orphan Europe prend des engagements pour la protec...” - Orphan EuropePromotion des droits de l'homme
“Takeda promeut les droits de l'homme dans toutes l...” - Takeda44% of similar organizations communicate on CSR issues
+2100 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports